2015
DOI: 10.7897/2277-4572.04219
|View full text |Cite
|
Sign up to set email alerts
|

Aprepitant, a Newer Antiemetic in Chemotherapy Induced Nausea and Vomiting

Abstract: Aprepitant is a recently introduced NK1 receptor antagonist. It effectively blocks Substance-P, which is supposed to have emetic action. Hence, this newer drug is being used in patients undergoing chemotherapy to prevent chemotherapy induced nausea and vomiting (CINV). This particular review article gives a bird's eye view on aprepitant, which is being tried as an adjuvant anti emetic in patients with far advanced cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 9 publications
0
0
0
Order By: Relevance